Drug-induced photosensitivity during tebentafusp treatment for metastatic uveal melanoma: A newly described occurrence

J Eur Acad Dermatol Venereol. 2023 Feb;37(2):e207-e208. doi: 10.1111/jdv.18625. Epub 2022 Oct 7.

Authors

Martina Lambertini^{1

2}, Francesca Comito³, Barbara Melotti³, Maria Francesca Baracca^{1

2}, Emi Dika^{1

2}

Affiliations

¹ Division of Dermatology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
² Division of Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
³ Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

PMID: 36177547
DOI: 10.1111/jdv.18625

No abstract available

Publication types

Letter

MeSH terms

Humans
Melanoma* / pathology
Neoplasm Metastasis
Uveal Neoplasms* / drug therapy

Substances

tebentafusp

Supplementary concepts

Uveal melanoma